DOCS.L

Dr. Martens plc
Dr. Martens PLC - Transaction by PCA of PDMR
26th September 2024, 13:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8571F
Dr. Martens PLC
26 September 2024
 

Dr. Martens plc 

Notification of transaction by Person Closely Associated with a PDMR

 

Dr. Martens plc (the ‘Company’) announces that on 26 September 2024 the following transaction in the Company’s ordinary shares was undertaken by a person closely associated with a director / person discharging managerial responsibility (‘PDMR’).
 

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

1.

Details of PDMR / person closely associated with them 

a)

Name

Katie Wilson

2.

Reasons for the notification

a)

Position / status

Person Closely Associated with Giles Wilson, 

Chief Financial Officer and PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Dr. Martens plc

b)

Legal Entity Identifier code

213800QPT8YM6NQZPH28

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of GBP 0.01 each


 ISIN: GB00BL6NGV24

b)

Nature of the transaction

Purchase of Ordinary Shares

c) 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.554

30,000

 

d)

Aggregated information

Aggregated volume

Price

 

N/A – single transaction

e)

Date of the transaction

26 September 2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUNVURSBUKUAR]]>
TwitterFacebookLinkedIn